Recce PharmaceuticalsRCE 
$0.342.02%24h
2.02%24h
Global rank23399
Market cap$59.58M
Change 7d-3.81%
YTD Performance-4.72%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings-$8.78M
Dividend yield-
Main Sector
Healthcare
Category
Recce Pharmaceuticals (RCE) Total Liabilities
RCE Total Liabilities in 2022: $3.45M
According to Recce Pharmaceuticals latest financial reports the total liabilities of RCE is $3.45M, an increase of 100.79% to 2022. At the end of 2022 company had $1.72M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Recce Pharmaceuticals is responsible for during its operational activities.
Recce Pharmaceuticals (RCE) Total Liabilities History from 2023 to 2022
-
Value:-
RCE Total Liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023 | $3.45M | 100.79% |
| 2022 | $1.72M | 117.54% |
| 2021 | $790.88K | 26.44% |
| 2020 | $625.50K | 8.09% |
| 2019 | $578.70K | - |
View the Top Total Liabilies Stocks
